Relay Historical Cash Flow
| RLAY Stock | USD 2.72 0.00 0.00% |
Analysis of Relay Therapeutics cash flow over time is an excellent tool to project Relay Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 4 M or Other Non Cash Items of 1.2 M as it is a great indicator of Relay Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Relay Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Relay Therapeutics is a good buy for the upcoming year.
Relay |
About Relay Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Relay balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Relay's non-liquid assets can be easily converted into cash.
Relay Therapeutics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Relay Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Relay Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Relay Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Relay Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relay Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Relay Stock please use our How to Invest in Relay Therapeutics guide.At this time, Relay Therapeutics' Change In Working Capital is fairly stable compared to the past year. Begin Period Cash Flow is likely to rise to about 179.5 M in 2025, whereas Sale Purchase Of Stock is likely to drop slightly above 1.3 M in 2025.
Relay Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Relay Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Relay Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 429.0M | 5.9M | 1.7M | 1.5M | 1.3M | 1.3M | |
| Investments | 81.7M | (450.7M) | (188.7M) | 51.0M | (41.1M) | (43.1M) | |
| Change In Cash | 405.7M | (165.8M) | (128.3M) | (7.9M) | (20.0M) | (19.0M) | |
| Stock Based Compensation | 32.0M | 48.5M | 56.1M | 86.0M | 94.1M | 50.9M | |
| Free Cash Flow | (104.4M) | (77.9M) | (238.6M) | (304.4M) | (251.1M) | (238.6M) | |
| Change In Working Capital | (85.2M) | 97.3M | 11.2M | (32.5M) | 14.6M | 15.4M | |
| Begin Period Cash Flow | 42.8M | 448.5M | 282.7M | 154.4M | 146.4M | 179.5M | |
| Total Cashflows From Investing Activities | (319.0M) | 81.7M | (479.5M) | (188.7M) | (169.9M) | (178.4M) | |
| Other Cashflows From Financing Activities | 1.2M | 5.9M | 5.2M | 4.5M | 4.3M | 4.0M | |
| Depreciation | 3.5M | 3.9M | 4.1M | 5.3M | (6.9M) | (6.5M) | |
| Other Non Cash Items | (416K) | 137.7M | (10.5M) | (17.2M) | 1.3M | 1.2M | |
| Capital Expenditures | 1.9M | 3.5M | 9.1M | 4.1M | 2.0M | 1.9M | |
| Total Cash From Operating Activities | (102.5M) | (74.4M) | (229.5M) | (300.3M) | (249.1M) | (236.7M) | |
| Change To Operating Activities | 1.3M | (2.1M) | 18.6M | 9.8M | 11.3M | 5.7M | |
| Issuance Of Capital Stock | 427.8M | 382.2M | 284.7M | 9.4M | 265.9M | 202.2M | |
| Net Income | (52.4M) | (363.9M) | (290.5M) | (342.0M) | (337.7M) | (354.6M) | |
| Total Cash From Financing Activities | 426.5M | 388.1M | 289.9M | 34.8M | 270.2M | 206.9M | |
| End Period Cash Flow | 448.5M | 282.7M | 154.4M | 146.4M | 126.4M | 185.6M | |
| Other Cashflows From Investing Activities | 83.6M | (450.7M) | (179.7M) | 101K | 90.9K | 95.4K | |
| Change To Netincome | 2.0M | 31.5M | 51.3M | 56.1M | 64.6M | 67.8M | |
| Change To Liabilities | 3M | (410K) | 21.9M | 21.8M | 25.1M | 26.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Relay Stock Analysis
When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.